BiotechTube

Riociguat (Adempas, BAY 63-2521)

Phase 1Completed
0 watching 0 views this week💤 Quiet
30
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Clinical Pharmacology

Conditions

Clinical Pharmacology

Trial Timeline

Apr 14, 2010 → Sep 15, 2011

NCT ID
NCT04366622

About Riociguat (Adempas, BAY 63-2521)

Riociguat (Adempas, BAY 63-2521) is a phase 1 stage product being developed by Bayer for Clinical Pharmacology. The current trial status is completed. This product is registered under clinical trial identifier NCT04366622. Target conditions include Clinical Pharmacology.

Hype Score Breakdown

Clinical
10
Activity
5
Company
7
Novelty
3
Community
2

Clinical Trials (2)

NCT IDPhaseStatus
NCT04366622Phase 1Completed
NCT04364464Phase 1Completed

Competing Products

20 competing products in Clinical Pharmacology

See all competitors
ProductCompanyStageHype Score
Lecanemab + PlaceboEisaiPhase 3
77
Cetuximab + CisplatinEli LillyPhase 2
52
Durvalumab + TremelimumabAstraZenecaPhase 1/2
41
PosaconazoleMerckApproved
85
Rebif®MerckPhase 3
77
Blinatumomab + olverembatinibAmgenPhase 2
51
Binimetinib + NivolumabBristol Myers SquibbPhase 2
51
Fluconazole (BAYT006267) 150 mg capsules + Fluconazole 150 mg capsules (DiflucanTM)BayerPhase 1
30
Finerenone (BAY 94-8862) PEG solution + Finerenone (BAY 94-8862) immediate release tablet + Eplerenone (Inspra®) + PlaceboBayerPhase 1
30
Rivaroxaban (BAY 59-7939, Xarelto) in ODT form + Rivaroxaban (BAY 59-7939, Xarelto) in film-coated formBayerPhase 1
30
Naproxen sodium and diphenhydramine hydrochloride soft capsules + Naproxen sodium and diphenhydramine hydrochloride coated tablets (Aleve PM, BAY98-7111)BayerPhase 1
30
Fulacimstat (BAY1142524)BayerPhase 1
30
Vilaprisan (BAY 1002670) + Vilaprisan Placebo + Microgynon + Microgynon PlaceboBayerPhase 1
30
Nifedipine gastrointestinal therapeutic system (GITS) (Adalat LA, BAY a1040) + Candesartan cilexetilBayerPhase 1
30
BAY1817080 + Placebo + ItraconazoleBayerPhase 1
30
BAY1902607 + PlaceboBayerPhase 1
30
Fosrenol ODT (Lanthanum Carbonate, BAY77-1931) + Fosrenol chewable Tablet (Lanthanum Carbonate, BAY77-1931)BayerPhase 1
30
Riociguat (Adempas, BAY63-2521) immediate release tablet of 2.5 mg + PlaceboBayerPhase 1
30
Neladenoson bialanate (BAY 1067197)BayerPhase 1
30
Riociguat (Adempas, BAY 63-2521)BayerPhase 1
30

Other Products from Bayer

TelmisartanApproved
82
Clotrimazole vaginal tablet + FluconazoleApproved
82
Levitra (Vardenafil, BAY38-9456)Approved
82
Avelox (Moxifloxacin, BAY12-8039) + Amoxicillin clavulanic acidApproved
82
Rivaroxaban 20 MG + WarfarinApproved
82